THE R46L POLYMORPHISM OF PCSK9 GENE AND LIPID PROFILE IN CAUCASIAN POPULATION OF RUSSIA

被引：0
|
作者：
Astrakova, K. [1 ]
Shakhtshneider, E. [2 ]
Ivanoshchuk, D. [2 ]
Ragino, Y. [1 ]
Astrakov, S. [3 ]
Voevoda, M. [2 ]
机构：
[1] Inst Internal & Prevent Med, Biochem Lab, Novosibirsk, Russia
[2] Inst Internal & Prevent Med, Med Genet Lab, Novosibirsk, Russia
[3] Novosibirsk State Univ, Fac Med, Novosibirsk, Russia
来源：
ATHEROSCLEROSIS | 2016年 / 252卷
关键词：
D O I：
10.1016/j.atherosclerosis.2016.07.362
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
EAS16-0875
引用
收藏
页码：E40 / E40
页数：1
相关论文
共 50 条
  • [1] R46L polymorphism in the PCSK9 gene: Relationship to lipid levels, subclinical vascular disease, and erectile dysfunction
    Mostaza, Jose M.
    Lahoz, Carlos
    Salinero-Fort, Miguel A.
    de Dios, Olaya
    Castillo, Elisa
    Gonzalez-Alegre, Teresa
    Garcia-Iglesias, Francisca
    Estirado, Eva
    Laguna, Fernando
    Sabin, Concesa
    Lopez, Silvia
    Cornejo, Victor
    de Burgos, Carmen
    Sanchez, Vanesa
    Garces, Carmen
    JOURNAL OF CLINICAL LIPIDOLOGY, 2018, 12 (04) : 1039 - 1046
  • [2] THE PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9 (PCSK9) R46L GENE POLYMORPHISM AND STATIN RESPONSE IN A TUNISIAN CORONARY ATERY DISEASE POPULATION
    Kallel, A.
    Omar, S.
    Ben Achour, W.
    Sbai, M.
    Mechmeche, R.
    Jemaa, R.
    Kaabachi, N.
    ATHEROSCLEROSIS, 2015, 241 (01) : E206 - E206
  • [3] The R46L variant in the PCSK9 gene is associated with plasma lipid levels and lower cardiovascular risk in UK men
    Scartezini, M.
    Whittall, R. A.
    Cooper, J. A.
    Humphries, S. E.
    ATHEROSCLEROSIS SUPPLEMENTS, 2007, 8 (01) : 49 - 49
  • [4] The Effects of the PCSK9 R46L Genetic Variant on the Human Plasma Proteome
    Benson, Mark
    Yang, Qiong
    Ngo, Debby
    Zhang, Ruibo
    Shen, Dongxiao
    Sinha, Sumita
    Farrell, Laurie
    Ramachandran, Vasan S.
    Larson, Martin
    Wang, Thomas J.
    Gerszten, Robert E.
    CIRCULATION, 2019, 140
  • [5] The PCSK9 gene R46L variant is associated with lower plasma lipid levels and cardiovascular risk in healthy UK men
    Scartezini, Marileia
    Hubbart, Christina
    Whittall, Ros A.
    Cooper, Jackie A.
    Neil, Andrew H. W.
    Humphries, Steve E.
    CLINICAL SCIENCE, 2007, 113 (11-12) : 435 - 441
  • [6] PCSK9 GENETIC VARIANT R46L IN A SPANISH POPULATION WITH MODERATE-HIGH CARDIOVASCULAR RISK
    Rey-Zamora, D.
    Fabregate-Fuente, R.
    Fabregate-Fuente, M.
    Tello-Blasco, S.
    Barrio-Carreras, D.
    Rodriguez-Guerrero, A.
    Reyes-Valdivia, A.
    Palomino-Antolin, A.
    Clemente-Vargas, I.
    Olariaga-Merida, E.
    Diaz-Dominguez, C.
    Saban-Ruiz, J.
    ATHEROSCLEROSIS, 2015, 241 (01) : E131 - E131
  • [7] REGIONAL DISTRIBUTION AND METABOLIC IMPACT OF PCSK9 INSLEU AND R46L GENE MUTATIONS AND APOE GENOTYPE
    Awan, Z.
    Awan, A.
    Delvin, E. E.
    Levy, E.
    Genest, J.
    Davignon, J.
    Seidah, N. G.
    Baass, A.
    CANADIAN JOURNAL OF CARDIOLOGY, 2013, 29 (10) : S164 - S164
  • [8] Regional Distribution and Metabolic Effect of PCSK9 insLEU and R46L Gene Mutations and apoE Genotype
    Awan, Zuhier
    Delvin, Edgard E.
    Levy, Emile
    Genest, Jacques
    Davignon, Jean
    Seidah, Nabil G.
    Baass, Alexis
    CANADIAN JOURNAL OF CARDIOLOGY, 2013, 29 (08) : 927 - 933
  • [9] PCSK9 R46L, Lower LDL and Cardiovascular Disease Risk in Familial Hype rcholesterolemia
    Baass, Alexis
    CIRCULATION, 2014, 130
  • [10] Carriers of the PCSK9 R46L Variant Are Characterized by an Antiatherogenic Lipoprotein Profile Assessed by Nuclear Magnetic Resonance Spectroscopy-Brief Report
    Verbeek, Rutger
    Boyer, Marjorie
    Boekholdt, S. Matthijs
    Hovingh, G. Kees
    Kastelein, John J. P.
    Wareham, Nicholas
    Khaw, Kay-Tee
    Arsenault, Benoit J.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2017, 37 (01) : 43 - +
12345